ctrl K

Watchlist Price Alert

Psyence Biomedical Ltd. (PBM)

NASDAQ: PBM · Real-Time Price · USD

4.65

-0.32 (-6.44%)

At close: Jun 12, 2025, 3:59 PM

4.65

0.00%

Pre-market: Jun 13, 2025, 07:31 AM EDT

Psyence Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	762.8K	128.68K	648.28K	4.75M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	257.73M	255M	n/a
Other Long-Term Assets	n/a	n/a	248.65K	n/a
Receivables	41.75K	149.37K	39.55K	138.07K
Inventory	n/a	n/a	-39.55K	n/a
Other Current Assets	29.61K	29.56K	324.94K	3.96K
Total Current Assets	1.13M	1.21M	973.22K	4.9M
Property-Plant & Equipment	5.49K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.49K	257.73M	255.25M	n/a
Total Assets	1.13M	258.93M	256.22M	4.9M
Account Payables	562.35K	1.63M	36.89K	13.45K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	10.45M	n/a	n/a	n/a
Other Current Liabilities	968.51K	12.48M	n/a	n/a
Total Current Liabilities	12.1M	14.27M	68.7K	101.08K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	19.51M	n/a
Total Liabilities	12.1M	14.27M	19.58M	101.08K
Total Debt	10.45M	n/a	n/a	n/a
Common Stock	46.13M	258.55M	255M	n/a
Retained Earnings	-57.46M	-13.9M	-18.36M	n/a
Comprehensive Income	361.06K	n/a	n/a	n/a
Shareholders Equity	-10.97M	244.66M	236.65M	4.8M
Total Investments	-29.61K	257.73M	255M	n/a